Company intelligence / Profile preview

BAAP Diagnostics

Liverpool, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

BAAP Diagnostics is a UK-based biotechnology company focused on developing rapid diagnostic tools to improve antimicrobial stewardship. Spun out from research at the University of Liverpool, the company utilizes host-response biomarkers to distinguish between bacterial and viral infections in patients, particularly children. Their technology aims to reduce unnecessary antibiotic prescribing and combat antimicrobial resistance by providing clinicians with actionable data at the point of care. The company's primary focus is on respiratory infections and sepsis management in acute care settings.

Therapeutic areas: Infectious Diseases
Modalities: DiagnosticHost-response biomarkers
Industry: Protein Biomarker Diagnostics

Partnerships

University of LiverpoolAlder Hey Children's Hospital

Beyond the preview

Go deeper on BAAP Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BAAP Diagnostics.

Explore the full profile